Number of shares and voting rights as at 30/09/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September.
Read the press release (in French)
General Meeting of Shareholders on 27 September 2018
- Quorum achieved: all resolutions suported by the Board of Directors have been approved
- Group's activity update
Europlasma announces the signature of a partnership framework agreement with Orano Cycle and the progress of discussions with financial investors to have a reference shareholder
Europlasma and Orano Cycle have signed today a framework partnership agreement that will allow Orano Cycle to leverage Europlasma's technologies and processes to accelerate its devolpment
Number of shares and voting rights as at 31/08/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st August.
Suspension of the automatic issuance of the 3rd warrant given access to convertible bonds
The company has suspended, today, the 3rd warrant given access to notes convertible into new shares (BEOCA).
Number of shares and voting rights as at 31/07/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st July.
Renewal of the convertible bonds financing contract
In the press release of February 9, 2018, Europlasma (the "Company") announced the conclusion of a convertible bond issue agreement (the "OCA") with the Luxembourg European High Growth Opportunity Securitization Fund (the "Investor"), renewable twice.
Number of shares and voting rights as at 30/06/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th June.
Half-year report on liquidity contract as at 30/06/2018
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 30 June 2018.